Aquestive Therapeutics Inc (AQST)
EBITDA Growth
-106.83%
Quarterly · Period ending:
AQST EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-106.83%period ending
Latest reported-106.83%period ending
AQST Quarterly EBITDA YoY % (308.37% → -106.83%)
Year-over-year change
High-resolution chart · PNG
AQST ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -106.8331% | |
| 78.3503% | |
| -116.2309% | |
| -54.2785% | |
| -651.7825% | |
| -119.8432% | |
| -194.7539% | |
| -1,092% | |
| 143.656% | |
| -185.2328% | |
| 57.9748% | |
| 92.729% | |
| 68.5733% | |
| 209.6438% | |
| 58.3716% | |
| -14.104% | |
| -123.3062% | |
| -15.9717% | |
| -71.4355% | |
| 44.878% | |
| -546.4463% | |
| 39.6364% | |
| -57.6729% | |
| 12.6265% | |
| 106.8073% | |
| -7.1149% | |
| 19.2519% | |
| -21.4985% | |
| 47.3941% | |
| -272.188% | |
| -58.8343% | |
| -208.3268% | |
| -1,026.6756% | |
| 308.3675% |